MedPage Today

Pathologic Variations in Antibody-Negative and Antibody-Positive Primary Biliary Cholangitis

—A recent study found that overall pathological changes of antibody-negative primary biliary cholangitis (PBC) were slightly milder than those of antibody-positive PBC, suggesting these 2 types of PBC ...
MedPage Today

In Colon Cancer, has a Better Predictor for Metastasis Been Identified?

"Understanding the rates of false-positives and false-negatives in lymph node assessment allows for better-informed surgical decision-making. This contributes to determining the extent of LN ...
Medscape

Lymph Node-positive Bladder Cancer

N1 Single lymph node metastasis, 2 cm or less in greatest dimension N1 Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node) N2 ...
Seeking Alpha

ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY ...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)-- Positive results from the DESTINY-Breast11 phase 3 trial showed ENHERTU ® (trastuzumab deruxtecan) followed by paclitaxel, trastuzumab and pertuzumab ...
Seeking Alpha

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early ...

Highest reported pathologic complete response rate seen in a Phase III registrational trial for HER2-positive early breast cancer with favorable safety profile vs. standard treatment DESTINY-Breast11 ...